Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)
 TO 
THE EDITOR
We and others have reported that a small proportion of Ph+ CML patients lack the M-BCR rearrangement since they have break points that fall outside M-BCR.
1,2 Some of these patients may express e1a2 BCR-ABL transcript. In another subset of patients, we previously described a new variant of BCR-ABL transcripts named c3a2 (or e19a2), 3, 4 which gives rise to a p230 kDa BCR-ABL protein, in which the breakpoint was positioned 3Ј part on BCR gene.
Herein, a novel type of the chimeric BCR-ABL mRNA transcript was detected in a patient with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) by reverse-transcription polymerase chain reaction (RT-PCR). Conditions for RT and PCR for BCR-ABL have been described 5, 6 ( Figure 1a ). In the initial screening by PCR, no product of amplification was found with AZ (ABL exon a2) and EA12 (BCR exon e11) primers (for e13a2 or e14a2 junctions hand, an atypical amplification product was detected using primer R112 (BCR exon e1) and AZ (for e13a2 junction), which was considerably larger than expected: 1145 vs 331 base pairs (bp) 6 ( Figure 1a ). BCR-ABL cDNA PCR products were directly sequenced and analyzed by FASTA3 analysis. 7 In both strands, the fragment investigated showed high homology between 5Ј part of exon 8 of the BCR gene (e8) and exon a2 of the ABL gene.
The homology with the exon 8 of BCR gene ended at nucleotide (nt) 107 807 of the reported BCR sequence.
2 Thirty-one bp of the fragment, positioned between the homologies of the BCR and ABL exons did not match either with BCR exon 8 or with the ABL sequences. Homology search demonstrated that this stretch of nucleotides matched with an intronic sequence of ABL intron Ib 2 spanning from nt 53 340 to 53 370. Homology of our BCR-ABL fragment with the second exon of the ABL gene was complete starting from nt 49 888 of the ABL2 clone, 2 corresponding to ABL exon 2. To our knowledge, no BCR break has hitherto been reported to fall in the BCR gene exon. In order to assess whether (1) the break on the BCR exon 8 fell inside the coding sequence and (2) the junction with ABL intron Ib sequences was due to a DNA link and not to a splice event, we performed the amplification on genomic DNA of the 5Ј BCR breakpoint region and a direct sequencing of the PCR product. (a) Schematic representation of BCR-ABL (e8-int-a2) mRNA transcripts. Our reported BCR-ABL fusion protein with molecular mass (p200) and its corresponding bcr-abl RNA type of junctions are indicated on the left side, respectively. Grey boxes, BCR exons not in scale numbered from e1 to e8; white boxes, ABL exons not in scale numbered from a2 to a11. Black box represents intron Ib inserted into the BCR exon 8 (part)-ABL exon 2 transcript. Primers AZ, R112 and EA500 used for RT-PCR for BCR and BCR-ABL were designed as arrows (primers Ex8 sense, and Int ABL antisense were used for single-step PCR for BCR-ABL on DNA). Some of the expected amplification product sizes with different combination of primers were designed as a ↔ and the corresponding number of base pairs (bp) is given above the lines. After amplification using a set of primers located on the BCR exon 8 (Ex8 sense) and on ABL intron Ib (int ABL antisense), the expected band of 125 bp was obtained. On the basis of the sequence analysis of the fragment, we could confirm that the break into BCR gene, in exon 8, occurred at DNA level and was located at position 53 340 of ABL intron Ib (Figure 1b) . Due to the fact that if BCR exon 8 (e8) (Figure 1b ) and ABL exon 2 ( Figure 1b ) are spliced they are not inframe, the insert of 31 nt from the ABL intron Ib sequences ( Figure  1b ) may be important to maintain the new type of BCR-ABL transcript in-frame (Figure 1b) . The sequences of ABL intron Ib 3Ј of the nt 53 370 revealed typical GT(GAGT) splice donor sequence (Figure 1b) . We checked for a possible splice acceptor sequence in the part of BCR exon 8 in the region 3Ј at the possible junction with the intronic sequence. We did not find any stretch at nucleotides resembling splice donor consensus sequence. The consequent BCR-int-ABL transcript was translated in a BCR-ABL protein slightly larger than p185 BCR-ABL and smaller than p210 BCR-ABL and p230 BCR-ABL: this protein of 1804 amino acid residues and with a molecular mass of 197.5 kDa was called p200 BCR-ABL. Furthermore, we observed that sequence motifs similar to consensus binding sites of the lymphoid-associated Translin protein are present on both participating strands at 22q11 and 9q34 recombination sites, respectively. No differences in clinical presentation of leukemia or laboratory findings at diagnosis were found between this patient who expressed the e8-int-a2 BCR-ABL transcript with respect to CML patients with expression of other bcrabl fusion types. Clinical outcome showed a good response to ␣-IFN therapy with complete hematological response and major karyotypic conversion. This is the first description of occurrences of either an intra-exonic break in the generation of a BCR-ABL fusion transcript or of insertion of intronic sequence to generate an in-frame BCR-ABL transcript. The preservation of the translational frame for bcr-abl supports the concept that this gene product is important for the development and maintenance of CML cell.
To our knowledge, this patient is one of the few Ph+ CML case with a breakpoint outside the M-bcr and the only one who expresses an e8-int-a2 BCR-ABL. Our data show that breakpoints outside M-bcr have to be considered in Ph+ CML and that variant BCR-ABL fusion transcripts and proteins can be expressed in Ph+ CML patients. 2, 8, 9 To our knowledge, this is also the first reported CML patient with a breakpoint located inside a BCR exon. Due to the fact that intra-exonic DNA breaks also represent an infrequent mechanism in AML translo-cation, 10 particularly in acute promyelocytic leukemia (APL), we searched for genomic similarities. The few specific studies in existence on sequence analysis of the PML-RAR␣ gene show that the breakpoint within the involved gene (usually the PML locus) is variably situated, and that the corresponding fusion transcript should be aberrant. The resulting PML-RAR␣ proteins contained residues not homologous with either PML or RAR␣. These reported atypical breaks were very similar to the one recorded in our case. A second original characteristic of the BCR break reported by us is that an intronic sequence derived from abl intron Ib was juxtaposed to bcr exon. This is another unprecedented feature for a CML patient, although on rare occasions it has been reported in AML patients. 10 So, it may be speculated that in a small proportion of the DNA breaks that occurs in leukemia, a currently unknown molecular mechanism could break the coding DNA. The resulting RNA remains in-frame coding an aberrant or, as in our case, variant oncogenic protein. The involvement of the Translin protein or Translin related protein (TRAX) 8 in the generation of our cases is strongly supported by the fact that homology sequences were present on both sides of the genes involved in the rearrangement. These observations support the hypothesis that the role of Translin could be more important in CML patients translocation than in other non-lymphoid leukemia-associated rearrangements.
G Martinelli The accepted definition of MW is that given by Brouet et al 2 in 1975. This disease is defined as bone marrow infiltration by lympho-plasmacytoid lymphocytes with a high level of circulating macroglobulin IgM. 2 The seric level of the IgM component should be over 5 g/l. Lymphadenopathy and splenomegaly occur in 20-40% of cases while gastrointestinal involvement has been reported in about 5-10% of cases.
It is now well demonstrated that different types of small B cell lymphomas may comprise a lympho-plasmacytoid/lymphoplasmacytic component. Immunohistochemistry demonstrates the presence of monotypic immunoglobulin in the cytoplasm, in the perinuclear cisternae and sometimes in expansion of this cisternae realizing intranuclear vacuoles 3 described by Dutcher and Fahey. 4 These vacuoles can also be disclosed by PAS staining, when the heavy chain is of the mu type.
At least three different types of small B cell lymphomas other than lymphoplasmacytic lymphoma can be associated with a WM presentation.
(1) Disseminated forms of gastro-intestinal low-grade MALT lymphoma have been well documented by Allez et al.
